![](/img/cover-not-exists.png)
29PPretreatment T790M mutation detection by ultrasensitive PCR assay as predictor of efficacy in non-small lung cancer (NSCLC) patients treated with 1st or 2nd generation EGFR tyrosine kinase inhibitors (TKIs)
Juan Vidal, O J, Simarro, J, Lorente Estelles, D, Pérez-Simó, G, Mancheno, N, Murria, R, Gomez Codina, J, Laiz, B, Palanca, SVolume:
30
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdz073.008
Date:
April, 2019
File:
PDF, 94 KB
2019